Industry › Healthcare & Pharm

Press Releases

Cornerstone Robotics Completes the World's First Clinical Validation of Autonomous Surgery Performed by Robot-Assisted Surgery

Aug 06, 2025 19:21 HKT/SGT

全球首例！康諾思騰手術機械人完成臨床場景下自主手術驗證

Aug 06, 2025 18:56 HKT/SGT

全球首例！康诺思腾手术机器人完成临床场景下自主手术验证

Aug 06, 2025 18:21 HKT/SGT

TruMerit Launches Global Credential for First-Level, General Nurses

Aug 06, 2025 09:00 HKT/SGT

全球首个IgA肾病对因治疗药物耐赋康®扩产获批云顶新耀加速提升可及性与产能布局

Aug 05, 2025 10:21 HKT/SGT

全球首個IgA腎病對因治療藥物耐賦康®擴產獲批雲頂新耀加速提升可及性與產能佈局

Aug 05, 2025 10:21 HKT/SGT

NEFECON(R) Receives NMPA Approval for Production Expansion in China,as Everest Medicines Accelerates Accessibility and Capacity Efforts

Aug 05, 2025 10:21 HKT/SGT

旅行者醫療支援平台 Traveler Care 正式全球上線，協助旅遊保險公司減少 80% 急診索賠

Aug 04, 2025 23:00 HKT/SGT

Traveler Care Launches Global Medical Dispatch Platform to Help Travel Insurance Companies Cut ER Claims by 80%

Aug 04, 2025 21:00 HKT/SGT

Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global Value of Its Proprietary Next-Generation Cancer Immunotherapies

Aug 02, 2025 00:02 HKT/SGT

雲頂新耀宣佈增加對I-Mab的戰略投資開發自研新一代腫瘤免疫療法的全球價值

Aug 01, 2025 23:48 HKT/SGT

云顶新耀宣布增加对I-Mab的战略投资开发自研新一代肿瘤免疫疗法的全球价值

Aug 01, 2025 23:45 HKT/SGT

Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI(R) (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC

Jul 31, 2025 08:30 HKT/SGT

New Data Presented at AAIC Demonstrates Investigational LEQEMBI(R) (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease

Jul 31, 2025 08:20 HKT/SGT

Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025

Jul 31, 2025 08:10 HKT/SGT

LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma

Jul 29, 2025 08:01 HKT/SGT

GEN 與 Sulfateq BV 公佈治療阿茲海默症及其他神經退化性疾病的候選藥物 SUL-238 的第一階段臨床試驗正面結果

Jul 29, 2025 08:00 HKT/SGT

GEN 与 Sulfateq BV 公布治疗阿尔茨海默病及其他神经退行性疾病的候选药物 SUL-238 的第一阶段临床试验积极结果

Jul 29, 2025 08:00 HKT/SGT

China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China

Jul 29, 2025 05:00 JST

China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China

Jul 29, 2025 04:00 HKT/SGT